Introduction {#s1}
============

G protein-mediated signalling plays a central role in regulation of cardiomyocyte function. Heterotrimeric G proteins consist of three subunits, Gα, Gβ, and Gγ. Agonist-occupied receptors induce dissociation of GDP from and binding of GTP to the G protein α subunit, resulting in G protein activation. Activated Gα and Gβγ subunits couple to a plethora of effectors, including enzymes and ion channels, and hence are involved in many regulatory processes [@pone.0024979-Hamm1], [@pone.0024979-Rockman1]. The role of stimulatory G~s~ and inhibitory G~i~ proteins in cardiac signalling pathways is well studied [@pone.0024979-Lohse1], [@pone.0024979-Xiao1]. Alterations of Gα~i~ protein expression levels are found in heart disease [@pone.0024979-Bohm1], and heart failure in humans leads to upregulation of Gα~i2~ and Gα~i3~ [@pone.0024979-Eschenhagen1], [@pone.0024979-Feldman1], [@pone.0024979-Neumann1], [@pone.0024979-Mittmann1]. Whether the upregulation of Gα~i2~ and Gα~i3~ in cardiomyocytes is causative, adaptive, or maladaptive still remains unclear.

Cardiac calcium channels are key components in complex signal transduction pathways and play an essential role in cardiac excitability and in coupling excitation to contraction [@pone.0024979-Schroder1]. One major pathway regulating calcium channels is mediated *via* G protein-mediated signalling. In the heart, the main sarcolemmal calcium channel is the voltage-dependent L-type calcium channel (L-VDCC). This channel is composed of three different subunits. The α~1~ subunit represents the pore forming subunit which contains the voltage sensor and the binding sites for calcium channel modulators [@pone.0024979-Abernethy1]. It associates with two auxiliary subunits, β, and α~2~δ [@pone.0024979-Xu1]. The functional properties of the pore forming subunit are differentially modified due to interaction with various β subunit isoforms [@pone.0024979-GonzalezGutierrez1], [@pone.0024979-Hullin1], [@pone.0024979-Jangsangthong1], [@pone.0024979-Link1]. Furthermore, receptor activated Gα~s~ protein stimulates L-VDCCs via adenylyl cyclase-mediated increases in cAMP levels and protein kinase A (PKA) activity [@pone.0024979-Lohse1]. Activation of G~i~ or G~o~ modifies channel function *via* diverse signal cascades [@pone.0024979-Wettschureck1]. Thus, G protein signalling pathways are crucial in determining and balancing cardiomyocyte function *in vivo*.

In a previous study we addressed the role of Gα~i2~ in β~2~-adrenergic receptor-mediated signalling. Gene deletion of Gα~i2~ in mice reduced single L-VDCC activity in β~2~-adrenergic receptor-transgenic mice [@pone.0024979-Foerster1], whereas pertussis toxin (PTX) treatment reversed this effect. We speculated that this unexpected effect of PTX may have been caused by inhibiting an upregulated Gα~i3~. Recently, Zuberi et al. [@pone.0024979-Zuberi1] showed that Gα~i2~ knockout leads to increased L-VDCC mRNA expression and a propensity towards ventricular arrhythmia. Muscarinic receptor-mediated inhibition of L-VDCC activity has been reported to depend on Gα~i2~ but not Gα~i3~ [@pone.0024979-Nagata1]. Though strongly suggested by these data, subtype-specific effects on cardiac L-VDCC by the highly homologous Gα~i2~ and Gα~i3~ isoforms remain unclear so far. Therefore, the present work was undertaken to elucidate whether the effects of these Gα~i~ proteins are redundant or distinct. Using cardiomyocytes from mice lacking Gα~i2~ or Gα~i3~ and wild-type (WT) control animals, we determined structural and functional changes. Further, we examined specific signalling pathways implicated in cardiac L-VDCC modulation by Gα~i~ protein. In this work, we provide evidence that the L-VDCC activity and kinetics are regulated in a non-redundant manner and we support this idea by demonstrating subtype-specific activation of the extracellular signal-regulated kinases 1/2 (ERK1/2) signalling cascade.

Results {#s2}
=======

Gα~i2~ deficiency decreases, while Gα~i3~ deficiency increases L-VDCC current density {#s2a}
-------------------------------------------------------------------------------------

To assess consequences of selective deletion of Gα~i2~ or Gα~i3~ genes, we measured whole-cell L-VDCC currents in cardiomyocytes from WT, Gα~i2~ ^−/−^, and Gα~i3~ ^−/−^ mice. Currents recorded at different test potentials are shown as representative original recordings and current-voltage diagrams of summarized data in [Fig. 1A and B](#pone-0024979-g001){ref-type="fig"}, respectively. In cardiomyocytes of Gα~i2~ ^−/−^ mice, the calcium current density at 0 mV was slightly but significantly reduced (−7.9±0.6 pA/pF, n = 11, p\<0.05) compared to WT (−10.7±0.5 pA/pF, n = 22). In contrast, current density in cardiomyocytes from Gα~i3~ ^−/−^ mice was increased (to −14.3±0.8 pA/pF, n = 14, p\<0.05 vs. WT). Of note, the peak current in Gα~i2~ ^−/−^ cardiomyocytes is shifted towards higher voltages. Comparison of time-dependent inactivation by fitting revealed no alterations of fast and slow time constants in all genotypes (e.g. at 0 mV, τ~fast~: WT = 18.4±1.0 ms, Gα~i2~ ^−/−^ = 26.9±4.0 ms and Gα~i3~ ^−/−^ = 15.1±2.1 ms; τ~slow~: WT = 95.3±4.2 ms, Gα~i2~ ^−/−^ = 97.5±17 ms and Gα~i3~ ^−/−^ = 94.9±9.9 ms; n = 10--13). To test whether changes in gating account for the observed differences in current density, we examined kinetic and steady state properties of activation and inactivation.

![Cardiac whole-cell L-type calcium currents.\
Representative original current traces obtained at different test potentials (A) and IV-curves (B) reveal an increase of calcium current in ventricular myocytes from mice lacking Gα~i3~ and a decrease in mice lacking Gα~i2~ as compared to WT mice. (C) Steady-state inactivation of Gα~i2~ ^−/−^ (n = 11) is shifted to more negative voltages as compared to Gα~i3~ ^−/−^ (n = 13, p\<0.05) and WT (n = 18, p\<0.05). (D) A slowing of the recovery time constant τ is found in cardiomyocytes from Gα~i2~ ^−/−^ mice (287±21 ms, n = 9) as compared to Gα~i3~ ^−/−^ cells (n = 9) and WT (n = 16).](pone.0024979.g001){#pone-0024979-g001}

L-VDCC kinetics are altered by Gα~i2~ deletion, but not by Gα~i3~ deletion {#s2b}
--------------------------------------------------------------------------

The steady-state inactivation properties ([Fig. 1C](#pone-0024979-g001){ref-type="fig"}) in Gα~i2~ ^−/−^ cardiomyocytes were altered compared to WT cells as reflected by a significant leftward shift of V~0.5~ (Gα~i2~ ^−/−^: −23.4±1.0 mV, n = 11, WT: −19.2±0.7 mV, n = 18) and an increased slope factor ([Table 1](#pone-0024979-t001){ref-type="table"}). In addition, recovery from inactivation was slowed in cardiomyocytes from mice lacking Gα~i2~ (τ: 287±21 ms, n = 9, p\<0.05) in comparison to WT animals (τ: 215±14 ms, n = 16; [Fig. 1D](#pone-0024979-g001){ref-type="fig"}). In contrast, whole-cell currents in cells form Gα~i3~ ^−/−^ mice were indistinguishable from WT regarding both steady state inactivation (V~0.5~: −18.2±0.9 mV, n = 13, [Table 1](#pone-0024979-t001){ref-type="table"}) and recovery from inactivation (τ: 203±24 ms, n = 9). Thus, currents from Gα~i2~ ^−/−^ mice show altered kinetic properties and this might explain the decreased current density described above ([Fig. 1](#pone-0024979-g001){ref-type="fig"}). Despite increased current density no alteration of current kinetics in Gα~i3~ ^−/−^ myocytes was visible. Thus we analyzed single-channel activity to elucidate the opposing effects seen on whole-cell currents in Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ cardiomyocytes.

10.1371/journal.pone.0024979.t001

###### Steady-state inactivation parameters.

![](pone.0024979.t001){#pone-0024979-t001-1}

  Parameter               WT                                      Gα~i2~ ^−/−^                                   Gα~i3~ ^−/−^
  ------------------- ----------- ----------------------------------------------------------------------------- --------------
  V~0.5~ (mV)          −19.1±0.7   −23.4±1.0[\*](#nt102){ref-type="table-fn"} [†](#nt103){ref-type="table-fn"}    −18.2±0.9
  Slope factor (mV)     5.2±0.2     8.7±0.6[\*](#nt102){ref-type="table-fn"} [†](#nt103){ref-type="table-fn"}      5.4±0.2

In Gα~i2~ ^−/−^ cardiomyocytes V~0.5~ of the steady-state inactivation is significantly shifted to more negative potentials. In addition, Boltzmann fits revealed a significant flattening of the curves as indicated by increased slope factors.

\*p\<0.05 vs. WT,

p\<0.05 vs. Gα~i3~ ^−/−^.

No major changes in gating properties of single L-VDCC in Gα~i3~ ^−/−^ cardiomyocytes {#s2c}
-------------------------------------------------------------------------------------

Single-channel current recordings in Gα~i3~ ^−/−^ cardiomyocytes revealed a trend towards increased peak ensemble average currents ([Fig. 2B](#pone-0024979-g002){ref-type="fig"}) and higher open probability ([Fig. 2C](#pone-0024979-g002){ref-type="fig"}) when compared to WT cardiomyocytes ([Table 2](#pone-0024979-t002){ref-type="table"}). These effects are based on a significant reduction of the mean closed time (3.8±0.5 ms vs. 6.6±0.9 ms, n = 6--7, p\<0.05; [Fig. 2D](#pone-0024979-g002){ref-type="fig"}). Together with a significantly decreased slow time constant of the closed state and by trend a reduced first latency ([Table 2](#pone-0024979-t002){ref-type="table"}) our single-channel data suggest that in Gα~i3~ ^−/−^ exit from deeper closed states of L-VDCC is facilitated. Given that single-channel activity in Gα~i2~ ^−/−^ mice was decreased by trend [@pone.0024979-Foerster1] our findings presented here suggest that Gα~i2~ ^−/−^ or Gα~i3~ ^−/−^ knockout leads to distinct changes of cardiac L-VDCC properties. Yet, these only slight functional changes alone do not elucidate the more remarkable augmentation of calcium current density in Gα~i3~ ^−/−^. Since the remaining Gα~i~ isoform might have compensated for effects of Gα~i3~ deficiency we next checked the expression levels of Gα~i2~ in Gα~i3~ knockouts and *vice versa*.

![Single-channel properties of L-type calcium channels.\
(A) Exemplary traces of barium currents show increased single-channel activity in ventricular myocytes of Gα~i3~ ^−/−^ animals vs. WT mice. (B) The peak ensemble average current is −61±13 fA in Gα~i3~ ^−/−^ (n = 6) and −44±9 fA in WT mice (n = 7). (C) The open probability within active sweeps is slightly enhanced in Gα~i3~ ^−/−^ (5.4±1.0% vs. 4.0±0.9% WT) whereas (D) the mean closed time is significantly reduced (Gα~i3~ ^−/−^ 3.8±0.5 ms vs. 6.6±0.9 ms WT). Unitary amplitude was not different with −0.83±0.02 pA (WT) and −0.79±0.03 pA (Gα~i3~ ^−/−^). \*p\<0.05 vs. WT. Box-and-whisker plots indicate minimum and maximum values as well as 25^th^, 50^th^ and 75^th^ percentiles.](pone.0024979.g002){#pone-0024979-g002}

10.1371/journal.pone.0024979.t002

###### Single-channel gating in WT and Gα~i3~ ^−/−^ myocytes.

![](pone.0024979.t002){#pone-0024979-t002-2}

  Parameter                                       WT                      Gα~i3~ ^−/−^
  ------------------------------------------ ------------ --------------------------------------------
  **i \[pA\]**                                −0.81±0.02                   −0.80±0.03
  **I~peak~ \[fA\]**                            −48±13                       −61±12
  **f~active~ (%)**                              76±4                         83±7
  **P~open~ (%)**                              4.2±1.1                      5.4±1.0
  **t~open~ \[ms\]**                          0.48±0.06    0.29±0.02[\*](#nt105){ref-type="table-fn"}
  **τ~open~ \[ms\]**                          0.42±0.05    0.26±0.03[\*](#nt105){ref-type="table-fn"}
  **t~closed~ \[ms\]**                         6.5±0.9      3.8±0.5[\*](#nt105){ref-type="table-fn"}
  **τ~closed,1~ \[ms\]**                      0.34±0.02                    0.36±0.04
  **τ~closed,2~ \[ms\]**                       15.5±1.5    10.2±1.7[\*](#nt105){ref-type="table-fn"}
  **proportion (τ~closed,1~∶τ~closed,2~)**     2.0±0.4                      2.2±0.3
  **fl \[ms\]**                                27.1±4.1                     18.6±2.4

Analysis of single-channel gating parameters in ventricular myocytes from WT (n = 7) and Gα~i3~ ^−/−^ (n = 6) mice. Recordings with more than one channel were excluded from the analysis. i: unitary current; I~peak~: peak ensemble average current; f~active~: fraction of traces showing at least one opening; P~open~: open probability in active traces; t~open~: mean duration of openings; τ~open~: dwell time constant of the open state; t~closed~: mean duration between two consecutive openings; τ~closed,1~: dwell time constant of the fast closed time component; τ~closed,2~: dwell time constant of the slow closed time component; proportion: ratio of events conferring to either the fast or the slow closed time component; fl: mean latency until the first opening.

\*: p\<0.05 vs. WT.

Enhanced expression levels of remaining Gα~i~ isoform {#s2d}
-----------------------------------------------------

If the generally accepted assumption holds true that Gα~i2~ and Gα~i3~ proteins are functionally redundant in the heart, we could expect a compensatory upregulation of the remaining Gα~i~ subunit after knockout of the other. We first determined mRNA expression levels for Gα~i1~, Gα~i2~, Gα~i3,~ and Gα~o~ in samples from WT, Gα~i2~ ^−/−^, and Gα~i3~ ^−/−^ mice using real-time PCR. In ventricular tissue from WT mice, transcripts for all Gα~i~ protein isoforms and Gα~o~ were found in different amounts ([Fig. 3A](#pone-0024979-g003){ref-type="fig"}). While Gα~i2~ and Gα~i3~ are known to be expressed in cardiomyocytes - with Gα~i3~ mRNA being clearly less abundant -, Gα~i1~ and Gα~o~ are likely transcribed in non-cardiomyocyte ventricular cells [@pone.0024979-Asano1]. Deletion of Gα~i2~ enhanced the mRNA level of Gα~i3~ (to 187±21%, n = 3, p\<0.05 vs. WT), as expected [@pone.0024979-Eschenhagen1], [@pone.0024979-Gohla1]. In cardiac tissue of Gα~i3~ ^−/−^ mice Gα~i2~ mRNA levels were upregulated to only 127±5% (n = 4, p\<0.05 vs. WT). No significant changes in Gα~o~ or Gα~i1~ mRNA expression levels were detected, which is in line with the assumption, that these G proteins are not expressed in cardiomyocytes (see above and [Fig. 3B](#pone-0024979-g003){ref-type="fig"}).

![RNA expression levels of cardiac Gα~i/o~ isoforms measured by real-time PCR.\
GAPDH was used as endogenous control, and WT mice as calibrator (expression = 100%; n = 4). (A) 2^−ΔCT^ values were calculated to analyze the relative expression of Gα~i/o~ isoforms in WT cardiomyocytes. (B) The relative mean expression (2^−ΔΔCT^) reveals a significantly increased Gα~i3~ mRNA content in ventricular tissue of Gα~i2~ ^−/−^ mice (n = 3) and significantly increased Gα~i2~ mRNA levels in Gα~i3~ ^−/−^ mice (n = 4). (C) Representative example of Gα~i2~ and Gα~i3~ protein expression in murine ventricular tissue from WT, Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ mice. Cell membranes were isolated and Gα~i~ proteins were analyzed by immunoblotting using an anti-Gα~common~ antibody. Shorter exposure times were used to analyse Gα~i2~ protein. (D) Summarized protein expression data show an upregulation of Gα~i3~ in Gα~i2~ ^−/−^ mice and an upregulation of Gα~i2~ in Gα~i3~ ^−/−^ mice (n = 8). \*p\<0.05 vs. WT.](pone.0024979.g003){#pone-0024979-g003}

Next, protein expression of Gα~i~ isoforms was analyzed in cell membrane preparations from WT, Gα~i2~ ^−/−^, and Gα~i3~ ^−/−^ ventricles by probing with Gα~common~ antibodies subsequent to high resolution urea/SDS-PAGE-separation of proteins. WT mice expressed both Gα~i2~ and Gα~i3~ subunits with the protein level of Gα~i2~ being much higher than that of Gα~i3~ ([Fig. 3C](#pone-0024979-g003){ref-type="fig"}), in line with previous studies (e.g. [@pone.0024979-Gohla1]). As expected, in hearts from Gα~i2~ ^−/−^ mice Gα~i3~ was found and Gα~i2~ was absent while in hearts from Gα~i3~ ^−/−^ mice, only Gα~i2~ was detectable ([Fig. 3C](#pone-0024979-g003){ref-type="fig"}). The specificity of the detected Gα~i2~ and Gα~i3~ protein bands in Gα~i2~ ^−/−^, Gα~i3~ ^−/−^ and WT cardiac tissue was confirmed by analyzing the expression of Gα~i~ isoforms by PTX-mediated \[^32^P\]ADP ribosylation [@pone.0024979-Exner1] (data not shown). These experiments prove that gene deletion indeed led to loss of the Gα subunit. Statistical analysis of relative expression levels obtained from immunoblots ([Fig. 3D](#pone-0024979-g003){ref-type="fig"}) show that Gα~i2~ protein is significantly upregulated in ventricles obtained from Gα~i3~ ^−/−^ mice (to 131±10%, n = 8, p\<0.05 vs. WT). However, Gα~i3~ protein is much more markedly upregulated upon Gα~i2~ deficiency (to 567±59%, n = 8, p\<0.05 vs. WT). Taken together, knockout models examined in this study feature a protein upregulation of the respective other Gα~i~ isoform. These data, together with quantitative mRNA data reported above, suggest that increased levels of Gα~i2~ or Gα~i3~ may partially compensate for the loss of the deleted other Gα~i~ isoform. Hence, any effect seen so far could be caused by the loss of one Gα~i~ protein and/or compensatory signalling exerted by the other. Unfortunately, double-deficient (Gα~i2~ ^−/−^/Gα~i3~ ^−/−^) mice are not viable [@pone.0024979-Gohla1] and hence cannot be used to directly address this question. However, all G~i~ proteins can acutely be inactivated by PTX treatment.

Acute G~i~ inactivation induces L-VDCC kinetic alterations in Gα~i3~ ^−/−^ cardiomyocytes {#s2e}
-----------------------------------------------------------------------------------------

We performed experiments with PTX for acute inactivation of G~i/o~ proteins in cardiomyocytes of WT and Gα~i~-deficient mice. Freshly isolated cardiomyocytes were incubated at 37°C with or without PTX for 3 hours and afterwards maintained and examined at room temperature. It has been shown that this protocol completely ablates G~i~-mediated signalling, e.g. when triggered by adenosine receptors [@pone.0024979-Xiao2]. Of note, the 3 hours incubation phase -- even in the absence of PTX -- reduced current density in Gα~i3~-deficient cells ([Fig. 4A](#pone-0024979-g004){ref-type="fig"}). Notably, similar to WT cells, PTX treatment in Gα~i3~ ^−/−^ myocytes induced a shift of V~0.5~ for steady state inactivation to more negative potentials (to −22.7±1.1 mV, n = 11; [Fig. 4B](#pone-0024979-g004){ref-type="fig"}). Likewise, the recovery from inactivation in Gα~i3~ ^−/−^ cardiomyocytes was slowed by PTX treatment (to τ: 350±27 ms, n = 8 p\<0.05 vs. WT; [Fig. 4C](#pone-0024979-g004){ref-type="fig"}). In contrast, the calcium current phenotype in Gα~i2~ ^−/−^ cells was preserved with time and resistant to treatment with PTX. To summarize, PTX alters channel regulation in cells from Gα~i3~ ^−/−^ but not from Gα~i2~ ^−/−^ mice. In Gα~i3~ ^−/−^, acute PTX treatment -- and thus inactivation of Gα~i2~ ^−/−^ -- mimics the kinetic changes induced by chronic gene deletion of Gα~i2~ ^−/−^. In contrast, the effect of Gα~i3~ gene deletion appears to be transient and does not interfere with channel kinetics. Because some of the calcium current changes reported here may be caused by (long-term) structural alterations rather than (acute) functional modulation of calcium channels, we next examined channel composition.

![Effects of acute inactivation of G~i/o~ proteins by PTX incubation of isolated cardiac myocytes.\
(A) Effects of PTX on peak L-VDCC current density. PTX treatment by itself did not affect calcium current density. (B) Effects of PTX on steady-state inactivation, as gauged by the midpoint voltage V~0.5~ of a Boltzmann function. No change is seen after 3 hours of drug-free incubation compared to 0 hour. PTX leads to a significant leftward shift of V~0.5~ in WT (from −19.2±0.7 mV to −21.0±0.7 mV, n = 7--18) and Gα~i3~ ^−/−^ (from −18.2±0.7 mV to −22.7±1.1 mV, n = 11--13). (C) PTX affects the recovery of the L-VDCC from inactivation. PTX inhibits the channel recovery in Gα~i3~ ^−/−^ (τ from 189±12 ms to 350±26 ms, n = 5--11). \*p\<0.05 vs. WT, ^†^p\<0.05 vs. Gα~i3~ ^−/−^, ^¶^p\<0.05 vs. 3 h without PTX.](pone.0024979.g004){#pone-0024979-g004}

No significant structural modification of L-VDCC {#s2f}
------------------------------------------------

To obtain insight into the effects of specific and constitutive Gα~i~-deficiency on L-VDCC structure and expression, we determined RNA expression levels of the pore forming Ca~v~α~1~ subunit and the predominant murine cardiac Ca~v~β subunit, Ca~v~β~2~ [@pone.0024979-Hullin1], [@pone.0024979-Link1], [@pone.0024979-Beetz1], which is involved in calcium channel trafficking and gating [@pone.0024979-Colecraft1], [@pone.0024979-Dolphin1], [@pone.0024979-PerezReyes1]. The Ca~v~β~2~ subunit mRNA expression in ventricles from Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ animals is not altered compared to WT expression profile ([Fig. 5B](#pone-0024979-g005){ref-type="fig"}). In Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ ventricles, the pore forming Ca~v~α~1~ subunit mRNA ([Fig. 5B](#pone-0024979-g005){ref-type="fig"}) and membrane protein ([Fig. 5C and D](#pone-0024979-g005){ref-type="fig"}) expression levels exhibit only slight and insignificant changes. Thus, these data do not suffice to explain the Gα~i~ isoform-specific regulation of the current density. Therefore, we next switched to the posttranslational level and addressed signalling pathways that are involved in G~i~ protein-mediated action.

![Calcium channel subunit expression.\
(A) 2^−ΔCT^ values were calculated against GAPDH expression to analyze the relation of L-type calcium channel subunits in WT cardiomyocytes (n = 4). (B) No significant changes in the relative mean expression (2^−ΔΔCT^) were observed in ventricular tissues from Gα~i2~ ^−/−^ (n = 3) and Gα~i3~ ^−/−^ mice (n = 4). (C) Representative example of Ca~v~α~1~ protein expression in murine ventricular tissue from WT, Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ mice. (D) Quantification of Ca~v~α~1~ protein levels show no change in ventricles from Gα~i3~ ^−/−^, Gα~i2~ ^−/−^ and WT mice (n = 3).](pone.0024979.g005){#pone-0024979-g005}

Akt activation is unaltered by deletion of Gα~i2~ or Gα~i3~ {#s2g}
-----------------------------------------------------------

Cardiac Gα~i~ is known to activate the PI3-kinase Akt/PKB pathway [@pone.0024979-Chesley1], and Akt-mediated β-subunit phosphorylation prevents Ca~v~α~1~ degradation [@pone.0024979-Catalucci1]. A G~i~-isoform-specific regulation of Akt could explain the calcium current increase in the case of Gα~i3~ ^−/−^ and decrease in case of Gα~i2~ ^−/−^. To examine the functional significance of Gα~i~-dependent activation of Akt *in vivo*, animals were treated with either saline or the muscarinic receptor agonist carbachol (CCh, 0.5 mg/kg body weight) by i.p. injection; 15 min later animals were killed, and signalling activity was assessed in heart preparations. Phosphorylation of Akt and its downstream effector glycogen synthase kinase-3α/β (GSK3α/β), were increased in cardiac tissue from all mouse strains after treatment with CCh ([Fig. 6A](#pone-0024979-g006){ref-type="fig"}). Although the basal phosphorylation of Akt in Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ cardiac tissue was slightly increased compared to WT (to 138±44% and 143±58% of WT, respectively), we could not observe statistically significant differences between CCh stimulated WT (233±14% to basal), Gα~i2~ ^−/−^ (201±27%) and Gα~i3~ ^−/−^ (195±25%) mice (each n = 3). Importantly, the total amount of Akt was not changed in all mice models. Thus, G~i~-subtype specific channel regulation seems to be independent of Akt phosphorylation in the investigated knockout models.

![Signalling events downstream of Gα~i~ stimulation.\
Representative western blot of cardiac tissues of animals treated either with saline or CCh (0.5 mg/kg body weight) for 15 min. (A) Western Blot and densitometry analyses of ventricular homogenates show that Akt phosphorylation was significantly and to a similar extent increased after CCh stimulation in all genotypes (n = 3). Total amount of Akt protein was unaltered and was used as loading control. (B) Western blot showing ERK1/2 phosphorylation and total ERK1/2 expression and bar graphs of combined results expressed as increase in pERK1/2 normalized to total ERK1/2 and compared to saline treated WT mice. The increase of ERK1/2 activation in CCh treated cells was markedly inhibited by Gα~i2~ gene deletion compared to WT and Gα~i3~ ^−/−^ mice (n = 3). \*p\<0.05 vs. WT NaCl.](pone.0024979.g006){#pone-0024979-g006}

Lack of Gα~i2~ protein abolishes ERK1/2 activation {#s2h}
--------------------------------------------------

Recently, a marked increase of L-type calcium channel density that involved PKC-dependent activation of the ERK1/2 pathway was reported [@pone.0024979-Smani1]. To determine its involvement, we measured the activation of ERK1/2 protein in total cardiac tissue. Gα~i2~ ^−/−^ mice demonstrated a significantly blunted increase of ERK1/2 phosphorylation in CCh-stimulated animals (128±5% to basal, n = 3) compared to WT (268±6%, n = 3) and Gα~i3~ ^−/−^ (192±20%, n = 3) cardiomyocytes. Of note, in Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ cardiac tissues, the basal ERK1/2 phosphorylation levels were increased compared to WT basal phosphorylation ([Fig. 6B](#pone-0024979-g006){ref-type="fig"}), while the total amount of ERK1/2 in the heart was the same in all mouse models tested. These results indicate a Gα~i2~-dependent ERK1/2 phosphorylation and strongly suggest that ERK1/2 plays an important role in isoform-specific Gα~i~ protein signalling.

Discussion {#s3}
==========

The two inhibitory G protein isoforms G~i2~ and G~i3~ are both upregulated in heart failure [@pone.0024979-Eschenhagen1], [@pone.0024979-Feldman1], [@pone.0024979-Neumann1]. One functionally important target of G~i~ protein signalling is the L-VDCC, the crucial trigger of cardiac excitation-contraction coupling. G~i~-protein-mediated inhibition of L-VDCC has been demonstrated for β~2~-adrenergic [@pone.0024979-Xiao1] and muscarinic [@pone.0024979-Nagata1] receptor signalling. In this context, we previously provided single-channel evidence that Gα~i2~ does not confer the L-VDCC inhibition observed in mice with chronic overexpression of the β~2~-adrenergic receptor [@pone.0024979-Foerster1]. On the other hand, cardiac Gα~i2~ (but not Gα~i3~) seems necessary and sufficient to mediate the muscarinic receptor-mediated L-VDCC inhibition [@pone.0024979-Nagata1], presumably through the classical adenylyl cyclase pathway. So far, no isoform-specific function could be assigned to cardiac Gα~i3~; however, G~i3~ has been shown to be an exclusive and specific regulator of autophagy in the liver [@pone.0024979-Gohla1], [@pone.0024979-Gohla2].

The different behaviour of L-VDCC currents obtained with isolated myocytes from Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ mice shown here and previously [@pone.0024979-Foerster1] demonstrates contrasting functional roles of these two Gα~i~ isoforms. Although the issue has also been addressed by others [@pone.0024979-Zuberi1], [@pone.0024979-Nagata1], [@pone.0024979-Chen1], our study is the first to demonstrate small but significant changes of basal whole-cell current density: a reduction in myocytes from Gα~i2~ ^−/−^ mice and an increase in myocytes from Gα~i3~ ^−/−^ mice. The altered steady-state inactivation and recovery observed with Gα~i2~ ^−/−^ under basal conditions ([Fig. 1C and D](#pone-0024979-g001){ref-type="fig"}), and with Gα~i3~ ^−/−^ myocytes after PTX treatment ([Fig. 4B and C](#pone-0024979-g004){ref-type="fig"}), point to a modulation of gating properties specific to Gα~i2~. In contrast to data presented here, Nagata *et al.* [@pone.0024979-Nagata1] did not detect a significant difference in L-VDCC activity between myocytes from WT, Gα~i2~ ^−/−^ and Gα~i3~ ^−/−^ mice. With respect to Gα~i2~ ^−/−^, this finding can be explained by the different prepulse potentials: the prepulse voltages (−50 mV used by Nagata and co-workers vs. −40 mV in our case) - intended to inactivate primarily sodium currents - lie within the descending part of steady-state inactivation ([Fig. 1C](#pone-0024979-g001){ref-type="fig"}). This likely translates into the more reduced peak in the current voltage plot in our study. Interestingly, Zuberi *et al.* [@pone.0024979-Zuberi1] compared Gα~i2~ ^−/−^ mice with Gα~i1~ ^−/−^/Gα~i3~ ^−/−^ double knockout mice and found distinct effects on surface ECGs: in Gα~i2~ ^−/−^ animals (but not in the double knockout mice), the effective refractory period was reduced and ventricular arrhythmias were induced more easily. In summary, Gα~i2~ protein deletion showed dramatic consequences on channel regulation *in vivo* and *ex vivo*.

There are no changes of cardiac L-VDCC composition regarding the main cardiac L-VDCC subunits, Ca~v~α~1~ and Ca~v~β~2~ ([Fig. 5B and D](#pone-0024979-g005){ref-type="fig"}) that would explain the obtained effects on current density. Furthermore, because of the compensatory upregulation of the remaining Gα~i~ isoform in case of either Gα~i2~ or Gα~i3~ deficiency ([Fig. 3B and D](#pone-0024979-g003){ref-type="fig"}), it is difficult to attribute the observed changes in L-VDCC regulation/function to the higher expression of one Gα~i~ isoform or to the loss of the other or to both. Therefore, given the novel functional effects reported here for cardiac Gα~i2~ and Gα~i3~, we have to consider a number of molecular pathways. For instance, activation of Stim1 [@pone.0024979-Park1] may lead to altered L-VDCC function and subcellular distribution. Enhanced endocytosis and degradation of calcium channels can also be mediated by activation of PIKfyve [@pone.0024979-Tsuruta1] and subsequent Ca~v~α~1~ targeting to lysosomes. Further, the RGK proteins Rad and Rem expressed in the heart [@pone.0024979-Finlin1] are appealing candidates, because they negatively regulate both membrane expression and gating of L-VDCC [@pone.0024979-Yada1], [@pone.0024979-Yang1] while little is known about how these small GTP-binding proteins are regulated themselves [@pone.0024979-Correll1]. In our present study, we focused on two other important molecular pathways since they are significantly regulated by G~i~-signalling. First, PI3-kinase Akt/PKB signalling is known to be activated by cardiac Gα~i~ [@pone.0024979-Chesley1], and Catalucci *et al.* [@pone.0024979-Catalucci1] revealed a mechanism through which the PI3-kinase Akt/PKB pathway modulates Ca^2+^ entry in cardiac cells via L-VDCC. Our data showed a CCh-induced Akt phosphorylation independent of the deletion of either Gα~i~ isoform ([Fig. 6A](#pone-0024979-g006){ref-type="fig"}). Second, it was demonstrated that deactivation of G~i~ leads to a significant reduction in ERK1/2 phosphorylation and that this effect was G~s~- and G~q~- independent [@pone.0024979-Chesley1], [@pone.0024979-DeGeorge1]. In the present study, we have shown that Gα~i2~ deletion prevents phosphorylation of ERK1/2. Recently, Smani *et al.* [@pone.0024979-Smani1] found a leftward shift and a marked increase in L-VDCC density induced by urocortin, which involved PKC-dependent activation of the MAPK-ERK1/2 pathway. Based on these findings we propose that loss of activation of L-VDCC by ERK1/2 might be a mechanism involved in functional regulation of calcium current in Gα~i2~ deficient mice.

A change of Gα~s~ mediated signalling might account for altered calcium currents when a Gα~i~ is lacking. With this caveat in mind, we demonstrated in our previous study that Gα~s~ protein expression remained unaffected in hearts from mice deficient in the major isoform Gα~i2~ [@pone.0024979-Foerster1]. Yet, possible changes in associated proteins like Gβγ subunits might indirectly affect Gα mediated signalling [@pone.0024979-Volkers1]. Indeed, we observed that expression of Gβ~1/2~ was slightly reduced in Gα~i2~ ^−/−^, but not Gα~i3~ ^−/−^ (data not shown). In any case, our single-channel analysis (in particular, the decrease in open time) does not support the idea of enhanced Gα~s~ mediated, cAMP-mediated signalling in Gα~i3~-deficient hearts ([Table 2](#pone-0024979-t002){ref-type="table"}).

The data presented here could not elucidate all effects seen in the knockout animals. Thus, eventually, G~i3~\'s role in L-VDCC regulation remains unclear, mainly in light of the absence of acute PTX effects in Gα~i2~ ^−/−^ mice. However, due to the effects seen by incubation without PTX, our findings suggest that the increment in channel activity observed in the absence of Gα~i3~ might be driven by an *in vivo* mechanism, which is not preserved *ex vivo* ([Fig. 4A](#pone-0024979-g004){ref-type="fig"}). It has also to be pointed out that the immunoblot data reveal total cardiac membrane channel protein levels, which does not necessarily match up the fraction of functional channels located in the sacrolemma. Given our currently available methods to analyze the subcellular localization of calcium channels and their regulation, all of these ideas require further work, which for technical reasons has to be done in recombinant systems.

Taken together, our data reported here and in a previous paper [@pone.0024979-Foerster1] point to the (patho-) physiological importance of subtype-specific G~i~ protein signalling in the heart. In particular, in terminal heart failure, Gα~i2~ upregulation now appears as an attractive mechanism linked to remodelling of L-VDCC [@pone.0024979-GonzalezGutierrez1], [@pone.0024979-Hullin1], [@pone.0024979-Jangsangthong1], [@pone.0024979-Link1]. Therefore, the present study provides new insights into potential mechanisms linking modulation of L-VDCC to the inhibitory G protein isoform G~i2~ in cardiomyocytes, and highlights G~i2~-specific signalling via ERK1/2. Further research needs to focus on detailed signalling pathways involving ERK1/2.

Methods {#s4}
=======

Ethic statement {#s4a}
---------------

Animal breeding, maintenance and experiments were approved by the responsible federal state authority (Landesamt für Natur-, Umwelt- und Verbraucherschutz Nordrhein-Westfalen; reference No. K 27, 24/04 and 8.87-51.05.20.09.232) and the responsible local authority (Umwelt- und Verbraucherschutzamt der Stadt Köln; reference No. 576/1.36.6.3.-47/08 Be). All animal experiments conform with the *Guide for the Care and Use of Laboratory Animals* published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Animals {#s4b}
-------

Generation, breeding and characterization of Gα~i2~- or Gα~i3~- deficient mice have been described previously [@pone.0024979-Foerster1], [@pone.0024979-Gohla1], [@pone.0024979-AlbarranJuarez1], [@pone.0024979-Jiang1], [@pone.0024979-Rudolph1], [@pone.0024979-Skokowa1]. All Gα~i~-deficient mouse strains used were backcrossed onto a C57Bl6 background for \>10 generations. Knockout and WT control mice were maintained at the animal facilities of the Heinrich-Heine-University, Düsseldorf, and of the Department of Pharmacology at the University of Cologne. Mice analyzed in this study were of both sexes, 3--9 months of age and weighted 20--35 g.

Genotyping {#s4c}
----------

Tail-clip analysis was performed on 3--4 weeks old mice. Genomic DNA was prepared and genotyping PCR for Gα~i2~ and Gα~i3~ was performed as described previously [@pone.0024979-Foerster1], [@pone.0024979-Jiang1].

Real time PCR {#s4d}
-------------

Primer for Gα~i1~, Gα~i2~, Gα~i3~ isoforms and Ca~v~α~1~ subunit were described previously [@pone.0024979-Beetz1], [@pone.0024979-Ruan1]. Specific primers for the Gα~o~ and Ca~v~β~2~ subunit were designed using Primer Express Software v3.0 (Applied Biosystems, Foster City, USA). For Gα~o~: 5′-TGGCATCGTAGAAACCCACTT-3′ (sense) and 5′-CGACGTCAAACAGCCTGAAG-3′ (antisense) and for Ca~v~β~2~: 5′-GGGAGGCAGTACGTAGAGAAGCT-3′ (sense) and 5′-TGCAAATGCAACAGGTTTT GTC-3′ (antisense). Total cellular RNA was extracted from murine heart (ventricle) according to the manufacturer\'s protocol (Qiagen QIAshredder and RNeasy Mini Kit, Qiagen, Hilden, Germany). For qualitative analysis of RNA integrity, 2 µg of total RNA was separated on a 1% formaldehyde agarose gel. Total RNA was subsequently converted into cDNA by ImProm-II Reverse Transcription Kit (Promega, Mannheim, Germany). Real-time PCR was carried out using the 7500 Real-Time PCR system (Applied Biosystems) under standard conditions with 200 pM PCR primers. Each sample was analyzed in triplets using SYBR green (Applied Biosystems) as fluorescent detector and GAPDH as endogenous control.

Cell membrane preparation {#s4e}
-------------------------

Murine cardiac ventricles were disrupted and homogenised in a lysis buffer containing 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.5 mM DTT, and an EDTA-free protease inhibitor cocktail (Roche, Penzberg, Germany) using an ultra-turrax blender. Cellular membranes were isolated by two steps of centrifugation at 450 g and 30.000 g. Membrane pellets were subsequently dissolved in a buffer consisting of a freezing supplement (70 mM Tris (pH 7.4), 12 mM MgCl~2~, 60% Glycerol, 240 µg/µl DNAse) and the lysis buffer in a ratio of 1∶6 in order to stabilize membrane-associated proteins.

Phosphorylation assay {#s4f}
---------------------

Animals were injected i.p. with 0.5 mg/kg carbachol (CCh) diluted in 0.9% normal saline. Sham injections were performed with 400 µl 0.9% saline per 30 g weight. After 15 min ventricular tissue was harvested and lysed in buffer (50 mM HEPES, 1% Triton, 50 mM NaCl, 10 mM Na~3~VO~4~, 0.1% SDS, 0.1 M NaF, 10 mM EDTA, complete mini protease inhibitor, pH 7.4) and left for 30 min at 4°C. Total cell lysates were extracted from the supernatant by centrifugation at 13.500 g for 20 min.

Immunoblotting {#s4g}
--------------

Gα~i~ and Ca~v~α~1~ proteins isolated from cell membranes were separated on 6 M urea/9% SDS-PAGE gels (protein content per lane was 90 µg) and on 8% SDS-PAGE gels (protein content per lane was 100 µg), respectively [@pone.0024979-Gohla1]. Protein kinase B/Akt and ERK1/2 in total cell lysates were separated on 10% SDS-PAGE gels (100 µg protein content per lane). Separated proteins were blotted onto nitrocellulose membranes (Hybond C extra; Amersham Bioscience). Gα~i~ proteins were detected with an anti-Gα~common~ antibody [@pone.0024979-Skokowa1] (1∶1000) and Ca~v~α~1~ with an anti-Ca~v~α~1~ antibody (1∶200; Sigma Aldrich). For detection of phosphorylation, membranes were incubated with phospho-Akt (Ser473), phospho-GSK3α/β (Ser21/9) and phospho-ERK1/2 (Thr202/Tyr204) antibodies. Membranes were reprobed with Akt and ERK1/2 antibodies (each 1∶1000; Cell Signalling) after stripping. Emitted light of stained membranes were captured on films and developed in different expositions. Protein densities were calculated using Aida Image Analyzer (Raytest, Straubenhardt, Germany) software. The Ras-GTP-activating protein (RasGAP; [@pone.0024979-Ikuno1]) was used as a loading control for Ca~v~α~1~. Equal loading on blotting membrane for Gα~i~ proteins was controlled by a non-specific protein staining using Ponceau S. Only blots with equal loading were analyzed. To confirm Gα~i~ band specificity, we performed ADP ribosylation of PTX-sensitive G proteins as described [@pone.0024979-Exner1].

Cardiomyocyte isolation {#s4h}
-----------------------

Single ventricular myocytes were isolated from hearts of 3--9 months old mice by enzymatic dissociation using a method described previously [@pone.0024979-Heubach1]. Only rod shaped cardiomyocytes were used for the experiments. Cells were maintained at room temperature and subjected to patch-clamp analysis. If indicated, a fraction of isolated ventricular myocytes was incubated without or with 1.5 µg/ml of PTX (Sigma Aldrich, St. Louis, USA) for 3 hours at 37°C [@pone.0024979-Xiao2].

Single-channel measurements {#s4i}
---------------------------

Single-channel patch clamp recordings were done in the cell-attached configuration as reported [@pone.0024979-Foerster1]. The composition of bath solution was (mM): K-glutamate 120, KCl 25, MgCl~2~ 2, HEPES 10, EGTA 2, CaCl~2~ 1, Na~2~-ATP 1, glucose 10 (pH 7.4 with KOH). Patch pipettes (7--9 MΩ) contained (mM): BaCl~2~ 70, HEPES 10, sucrose 110 (pH 7.4 with TEA-OH). Barium currents were recorded at room temperature using a holding potential of −100 mV and depolarizing test pulses to +20 mV (duration 150 ms, frequency 1.66 Hz, 180 sweeps per experiment minimum). Data were sampled at 10 kHz and filtered at 2 kHz using an Axopatch 200A amplifier (Axon Instruments, Sunnyvale, CA, U.S.A.). Only experiments with one single active channel in the patch were analyzed (identified by the lack of stacked openings).

Whole-cell current measurements {#s4j}
-------------------------------

Conventional whole-cell patch clamp recordings were performed with cells maintained at room temperature in bath solution containing (mM): NaCl 137, CsCl 5.4, CaCl~2~ 2, MgCl~2~ 1, glucose 10, HEPES 10 (pH 7.4 with NaOH). Pipette (2--3 MΩ) solution was composed of (mM): CsCl 120, MgCl~2~ 1, Mg-ATP 4, EGTA 10, HEPES 5 (pH 7.2 with CsOH). Giga-Ohm seals (resistance 2--5 GΩ) were formed by gentle suction. At the beginning of each experiment, membrane capacitance was measured by means of fast depolarizing ramp pulses from −80 to −85 mV over 25 ms. Cells were depolarized from a holding potential of −80 mV to a 50 ms prepulse to −40 mV in order to inactivate sodium channels. This was followed by test pulse voltages ranging from −40 to +50 mV in 10 mV steps (pulse duration 150 ms). For time-dependent inactivation, the declining raw currents at −10, 0, +10, +20 and +30 mV were fitted by a double-exponential function, yielding fast and slow time constant. For investigation of gating kinetics, standard two-pulse protocols were used: the voltage-dependent inactivation was measured after a prepulse of variable amplitude and 250 ms duration, followed by a test pulse of fixed amplitude for 50 ms. The midpoint voltage V~0.5~ was determined by fitting a Boltzmann function to the data. Recovery from inactivation was determined by two 200 ms depolarizing voltage pulses to 0 mV. The interpulse interval at a holding potential of −45 mV was increased from 50 to 375 ms in 25 ms steps. Recovery was fitted by a mono-exponential function, yielding the recovery time constant τ.

Statistical analysis {#s4k}
--------------------

Data are presented as means ± SEM. Patch-clamp data were analyzed using pClamp software (CLAMPEX 6 and FETCHAN, Axon Instruments). Analysis of L-VDCC kinetics was performed as described previously [@pone.0024979-Meszaros1] using GraphPad Prism 4. A one-sample t-test was used to analyze normalized data. Differences between genotypes were analyzed by one-way ANOVA followed by Dunnett\'s or Tukey\'s post test, and between treatments within one given genotype by two-tailed Student\'s t tests. For electrophysiological statistics, number of cardiomyocytes from a minimum of 3 animals, and for molecular biology statistics, number of animals was evaluated. P values\<0.05 were considered statistically significant.
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